Sendad, Amerah .
HRN: 07-53-21 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2025
CEFUROXIME 1.5GM (VIAL)
09/04/2025
09/06/2025
IV
1.5g
Q8hrs
Inconplete Abortion
Checking Initial Appropriateness
09/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/06/2025
09/12/2025
IV INFUSION
500mg
Q8
Post D&C
Checking Initial Appropriateness
09/06/2025
CEFUROXIME 1.5GM (VIAL)
09/06/2025
09/13/2025
IVT
1.5g
Q8
S/p CS
Checking Initial Appropriateness